Association between HLA phenotype and HLA concentration in plasma or platelets.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Human Immunology

• Publication date

  1988-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0198-8859(88)90086-9PMID 3284856
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Selective elution of HLA antigens and β2‐microglobulin from human platelets by chloroquine diphosphate

  1988cited by this paper
• Plasma and platelet HLA in normal individuals: quantitation by competitive enzyme-linked immunoassay.

  1987cited by this paper
• HLA antigens on red cells

  1987cited by this paper
• Two forms of HLA class I molecules in human plasma.

  1987cited by this paper
• Class I HLA molecules on human erythrocytes. Quantitation and transfusion effects.

  1987cited by this paper
• Quantitative analysis of platelet surface HLA by W6/32 anti-HLA monoclonal antibody.

  1986cited by this paper
• Secretion of HLA-A and -B antigens via an alternative RNA splicing pathway

  1986cited by this paper
• Expression of HLA class I antigens on hepatocytes in liver disease.

  1986cited by this paper
• Quantitative analysis of platelet surface HLA by W6/32 anti-HLA monoclonal antibody

  1986cited by this paper
• Induction of MHC-determined antigens in the lung by interferon-gamma.

  1986cited by this paper
• HLA antigens on red cells. Implications for achieving low HLA antigen content in blood transfusions

  1986cited by this paper
• Distribution of human Class I (HLA-A,B,C) histocompatibility antigens in normal and malignant tissues of nonlymphoid origin.

  1984cited by this paper
• HLA-B7 on human red blood cells. Improved detection by a radioactive anti-IgG test.

  1982cited by this paper
• Ability of thrombocytes to acquire HLA specificity from plasma.

  1982cited by this paper
• Two subgroups of HLA Bw44 defined by cell-mediated lympholysis that differ in Bw44 expression on platelets and in patterns of genetic linkage disequilibrium.

  1982cited by this paper
• Major histocompatibility antigens: the human (HLA-A, -B, -C) and murine (H-2K, H-2D) class I molecules.

  1981cited by this paper
• Quantitative analysis of cell surface HLA structures by means of monoclonal antibodies.

  1980cited by this paper
• MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.

  1979cited by this paper
• Type I diabetes mellitus

  1978cited by this paper
• Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture.

  1978cited by this paper
• Biologic and chemical characterization of HLA antigens in human serum.

  1977cited by this paper
• The major histocompatibility complex - genetics and biology (third of three parts).

  1976cited by this paper
• The Major Histocompatibility Complex — Genetics and Biology

  1976cited by this paper
• Evaluation of two sources of soluble HL‐A antigens: platelets and serum

  1974cited by this paper
• T cell recognition of cell‐surface antigens. II. Antigen recognition is necessary yet not sufficient for triggering T cell‐mediated immunity

  1974cited by this paper
• HISTOCOMPATIBILITY ANTIGENS OF HUMAN PLASMA: Localization to the HLD-3 Lipoprotein Fraction

  1973cited by this paper
• Soluble HL-A7 antigen: localization in the beta-lipoprotein fraction of human serum.

  1970cited by this paper
• Anti HL-A2 Inhibitor in Normal Human Serum

  1970cited by this paper
• Soluble HL-A7 Antigen: Localization in the β-Lipoprotein Fraction of Human Serum

  1970cited by this paper
• Anti HL-A2 Inhibitor in Normal Human Serum

  1970cited by this paper
• Experimental Designs, 2nd Edition

  1950cited by this paper

• Current Status of and Global Trends in Platelet Transfusion Refractoriness From 2004 to 2021: A Bibliometric Analysis

  2022cites this paper
• The Potential of Soluble Human Leukocyte Antigen Molecules for Early Cancer Detection and Therapeutic Vaccine Design

  2020cites this paper
• Risk factors, management and prevention of transfusion-related acute lung injury: a comprehensive update

  2019cites this paper
• Technology Medicine Open Access book

  2017cites this paper
• Transfusion-related acute lung injury: transfusion, platelets and biological response modifiers

  2016cites this paper
• Applications of Flow Cytometry in Solid Organ Allogeneic Transplantation

  2012cites this paper
• Transfusion-Related Acute Lung Injury in Children with Hematological Malignancies

  2011cites this paper
• TRALI-new challenges for histocompatibility and immunogenetics in transfusion medicine.

  2011cites this paper
• Antibody‐mediated (immune) transfusion‐related acute lung injury

  2011cites this paper
• In vitro assessment of platelet storage lesion in leucoreduced random donor platelet concentrates.

  2010cites this paper
• Transfusion-related acute lung injury (TRALI): A Canadian blood services research and development symposium.

  2010cites this paper
• Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody‐mediated transfusion‐related acute lung injury

  2009cites this paper
• Leucocyte antibody screening of donors for the prevention of TRALI

  2009cites this paper
• Transfusion-related acute lung injury (TRALI): current concepts and misconceptions.

  2009cites this paper
• The role of neutrophils in the pathogenesis of transfusion-related acute lung injury.

  2009cites this paper
• Transfusion‐related immunomodulation by platelets is dependent on their expression of MHC Class I molecules and is independent of white cells

  2008cites this paper
• Specificities of leucocyte alloantibodies in transfusion‐related acute lung injury and results of leucocyte antibody screening of blood donors

  2008cites this paper
• Platelets do not adsorb HLA class I molecules during storage of pooled platelet concentrates

  2006cites this paper
• Recombinant dimeric MHC antigens protect cardiac allografts from rejection and visualize alloreactive T cells

  2005cites this paper
• Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA‐G expression correlates with malignant transformation, high inflammatory infiltration and HLA‐A1 genotype

  2004cites this paper
• Variable Forms of HLA Class I Molecules in the Serum of Liver Transplant Recipients

  2004cites this paper
• Soluble HLA-I (s-HLA-I) synthesis in systemic lupus erythematosus

  2003cites this paper
• Soluble HLA-II expression in African-Americans

  2002cites this paper
• Increased level of soluble HLA class I antigens in systemic lupus erythematosus: correlation with anti-DNA antibodies and leukopenia.

  2001cites this paper
• Elevated level of soluble HLA class I antigens in serum and bronchoalveolar lavage fluid in patients with sarcoidosis.

  2001cites this paper
• Mechanisms for genetically predetermined differential quantitative expression of HLA-A and -B antigens.

  2000cites this paper
• High concentration of soluble HLA-DR in the synovial fluid: generation and significance in "rheumatoid-like" inflammatory joint diseases.

  2000cites this paper
• Increased serum concentrations of soluble HLA-class I antigens in hepatitis C virus related mixed cryoglobulinaemia

  2000cites this paper
• Thrombocyte HLA molecules retain nonrenewable endogenous peptides of megakaryocyte lineage and do not stimulate direct allocytotoxicity in vitro.

  2000cites this paper
• Mechanisms and new approaches for the allogeneic blood transfusion-induced immunomodulatory effects.

  2000cites this paper
• Soluble HLA Class I, HLA Class II, and Fas Ligand in Blood Components: A Possible Key to Explain the Immunomodulatory Effects of Allogeneic Blood Transfusions

  1999cites this paper
• Parasitic infection with Trichuris trichiura influences plasma levels of soluble HLA class I.

  1999cites this paper
• Serum levels of beta-2-microglobulin-free heavy chain of HLA class I antigen in healthy individuals: relationship to their class I allotype.

  1999cites this paper
• Soluble HLA class I, HLA class II, and Fas ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood transfusions.

  1999cites this paper
• Soluble HLA in human body fluids.

  1999cites this paper
• The reduction of HLA class I expression on platelets: a potential approach in the management of HLA-alloimmunized refractory patients.

  1999cites this paper
• Role of class-II major histocompatibility complex (MHC)-antigen-positive donor leukocytes in transfusion-induced alloimmunization to donor class-I MHC antigens.

  1998cites this paper
• Soluble HLA: a review of the literature.

  1998cites this paper
• Soluble HLA class I antigens in plasma of patients with malignant melanoma.

  1998cites this paper
• Soluble HLA-I in rheumatic diseases.

  1998cites this paper
• Quantitation of soluble HLA antigens in human serum.

  1997cites this paper
• Soluble HLA class I antigens in patients with type I diabetes and their family members.

  1997cites this paper
• [A study of the association between HLA phenotype and serum concentration of soluble HLA class I].

  1997cites this paper
• Synchronous decline of serum-soluble HLA class I antigen and beta-cell function in insulin-dependent diabetes mellitus.

  1997cites this paper
• Elevated serum HLA class I levels coincide with acute and chronic graft-versus-host disease

  1997cites this paper
• Soluble HLA class I antigens in pediatric patients with renal transplants from related living donors without acute rejection and treated with triple therapy.

  1996cites this paper
• Association of serum concentration of soluble class I HLA with HLA allotypes.

  1996cites this paper
• Induction of humoral immune tolerance to major histocompatibility complex antigens by transfusions of UVB-irradiated leukocytes.

  1996cites this paper
• Elevated serum level of soluble HLA class I antigens in patients with systemic lupus erythematosus.

  1996cites this paper
• Soluble class I HLA antigens in patients with rheumatoid arthritis and their families.

  1995cites this paper
• Detection of alloantibodies by flow cytometry: relevance to clinical transplantation.

  1995cites this paper
• QUANTIFICATION AND MOLECULAR ANALYSIS OF PLASMATIC HLA‐BCw MOLECULES WITH A LOCUS B AND Cw HLA SPECIFIC mAb (B1.23.2mAb)

  1995cites this paper
• DETECTION EFFICACY OF SOLUBLE HLA‐A, B ANTIGENS USING 1D‐IEF

  1994cites this paper
• HLA Antigens on Leukocyte Fragments and Plasma Proteins: Prestorage Leukoreduction by Filtration

  1994cites this paper
• Soluble HLA class I and class II in Japanese.

  1994cites this paper
• Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ.

  1994cites this paper
• Typing of a panel of soluble HLA class I antigens by enzyme-linked immunosorbent assay.

  1994cites this paper
• Quantitative and biochemical characterization of soluble HLA class I antigens shed by cultured human cells.

  1994cites this paper
• Quantification of serum-soluble HLA class I antigens in patients with gastric cancer.

  1994cites this paper
• Soluble MHC class I antigens (sHLA) and anti-HLA antibodies in heart and kidney allograft recipients.

  1993cites this paper
• Summary report from the first international workshop on soluble HLA antigens. Paris, August 1992.

  1993cites this paper
• The presence of messenger RNA for HLA class I in human platelets and its capability for protein biosynthesis

  1993cites this paper
• Ouantitation of granulocyte antibodies in sera and determination of their binding sites

  1992cites this paper
• Leukocyte Reduction in Blood Component Therapy

  1992cites this paper
• Soluble HLA class I and class II concentrations in commercial immunoglobulin preparations.

  1992cites this paper
• Soluble HLA-DR molecules in patients with HLA class II versus class I associated disorders.

  1991cites this paper
• Effect of HLA phenotype and gender on expression of various forms of class I HLA in plasma.

  1991cites this paper
• Use of 8-methoxypsoralen and ultraviolet-A pretreated platelet concentrates to prevent alloimmunization against class I major histocompatibility antigens.

  1991cites this paper
• Plasma MHC class I expression in cardiac graft patients: donor-specific soluble antigen in a presensitised graft patient.

  1991cites this paper
• Structural and functional characterization of HLA-DR molecules circulating in the serum.

  1991cites this paper
• Use of 8-methoxypsoralen and ultraviolet-A pretreated platelet concentrates to prevent alloimmunization against class I major histocompatibility antigens

  1991cites this paper
• CHARACTERIZATION OF SOLUBLE HLA MOLECULES IN SWEAT AND QUANTITATIVE HLA DIFFERENCES IN SERUM OF HEALTHY INDIVIDUALS

  1990cites this paper
• HLA Humoral Allosensitization

  1990cites this paper
• HLA class I expression on erythrocytes and platelets from patients with systemic lupus erythematosus, rheumatoid arthritis and from normal subjects

  1990cites this paper
• Review and update of platelet alloantigen systems.

  1990cites this paper
• A study of HLA (Bg) on red cells and platelets by immunoblotting with monoclonal antibodies

  1990cites this paper
• Platelet crossmatching for kidney transplants by flow cytometry.

  1989cites this paper
• ALLOTYPING FOR HLA CLASS I USING PLASMA AS ANTIGEN SOURCE

  1989cites this paper
• Stability of platelet and plasma HLA concentrations in healthy adults or random‐donor platelet concentrates

  1989cites this paper
• Quantification of soluble HLA class I gene products by an enzyme linked immunosorbent assay

  1989cites this paper